Actively Recruiting

Phase 4
Age: 22Years - 27Years
FEMALE
NCT04910802

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Led by Miriam Elfström · Updated on 2021-09-16

150000

Participants Needed

1

Research Sites

347 weeks

Total Duration

On this page

Sponsors

M

Miriam Elfström

Lead Sponsor

K

Karolinska University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study aims to evaluate whether organised, concomitant HPV vaccination and HPV screening offered to all resident women aged 22-27 will result in a more rapid elimination of HPV infection in Sweden. This objective will be examined at the population level.

CONDITIONS

Official Title

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Who Can Participate

Age: 22Years - 27Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 22 to 26 years who live in Sweden
  • Women who have not opted out of the cervical screening program
  • Women who consent to participate in the study
  • Women attending cervical screening who agree to HPV testing and vaccination
  • Vaccination offered regardless of prior HPV vaccination or screening results
Not Eligible

You will not qualify if you...

  • History of severe allergic reaction to any HPV vaccine components, including Gardasil 9 ingredients
  • Known immune-related disorders
  • Current severe fever or acute illness (except minor infections like a cold or mild respiratory infection)
  • Received immunoglobulin or blood-derived products within 6 months before first HPV vaccine dose
  • Current pregnancy
  • Women who have had a total hysterectomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cancer prevention, screening, and counseling unit, Regional Cancer Center of Stockholm-Gotland

Stockholm, Sweden, 10239

Actively Recruiting

Loading map...

Research Team

M

Miriam Elfström, PhD

CONTACT

H

Helena Andersson, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here